Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04280926 · ClinicalTrials.gov registry record
Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction
A clinical trial, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT04280926 is a clinical trial that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 1,000 participants.
The verdict
NCT04280926 has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Examine the analytical and clinical performance of Atellica IM TnIH assay for the diagnosis and rule out of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.
Interventions
- DIAGNOSTIC_TEST Cardiac Troponin Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2020-10-13 |
| Est. Completion | 2024-10-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04280926
The ClinicalTrials.gov registry entry for NCT04280926 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Troponin Testing is the first listed.
NCT04280926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04280926 about?
NCT04280926 is a clinical study titled "Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction". Examine the analytical and clinical performance of Atellica IM TnIH assay for the diagnosis and rule out of acute myocardial injury and myocardial infarction in patients presenting to the emergency department in whom serial cTnI measurements are obtained on clinical indication.
What is the current status of trial NCT04280926?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2020-10-13. Estimated completion is 2024-10-13.
What interventions are being tested in trial NCT04280926?
The interventions under investigation include: Cardiac Troponin Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04280926?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.